申请人:SCHERING CORPORATION
公开号:EP1818325A2
公开(公告)日:2007-08-15
There are disclosed compounds of the formula
or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
已公开的化合物式如下
或其药学上可接受的盐或溶液,可用于治疗由趋化因子介导的疾病,如急性和慢性炎症性疾病和癌症。